Related Experiment Video
Updated: Oct 5, 2025

Visualization of Bacterial Resistance using Fluorescent Antibiotic Probes
Published on: March 2, 2020
Synthesis and Encapsulation of Ajuga parviflora Extract with Zeolitic Imidazolate Framework-8 and Their Therapeutic
Ab Majeed Ahanger1, Suresh Kumar1, Atul Arya1
1Medicinal Plant Research Laboratory, Department of Botany, Ramjas College, University of Delhi, New Delhi 110007, India.
Abstract:
Infectious diseases caused by bacteria have become a public health issue. Antibiotic therapy for infectious disorders, as well as antibiotic overuse, has resulted in antibiotic-resistant bacterial strains. Zeolitic imidazolate framework-8 (ZIF-8) possesses a wide surface area, high porosity, variable functionality, and potential drug carriers. We have established a clear method for making a nanoscale APE@ZIF-8 nanocomposite agent with outstanding antibacterial activity against methicillin-resistant Staphylococcus aureus (MRSA) and cephalosporin-carbapenem-resistant Escherichia coli (CCREC). We present a unique approach for encapsulating molecules ofAjuga parviflora extract (APE) with ZIF-8. APE@ZIF-8 has a positive charge. By electrostatic contact with the negatively charged bacterial surface of S. aureus and E. coli, APE@ZIF-8 NPs produce reactive oxygen species (ROS) that damage bacterial cell organelles. As a result, the APE@ZIF-8 nanocomposite offers limitless application potential in the treatment of infectious disorders caused by drug-resistant gram-positive and gram-negative bacteria.
Insights
A novel APE@ZIF-8 nanocomposite effectively combats antibiotic-resistant bacteria like MRSA and CCREC. This positively charged agent uses reactive oxygen species to damage bacterial cells, offering a promising new treatment for infectious diseases.
Area of Science:
- Materials Science
- Nanotechnology
- Microbiology
Background:
- Antibiotic resistance is a growing global health concern.
- Overuse of antibiotics has led to the emergence of resistant bacterial strains.
- Zeolitic imidazolate framework-8 (ZIF-8) shows potential as a drug delivery vehicle due to its properties.
Purpose of the Study:
- To develop a nanoscale APE@ZIF-8 nanocomposite agent.
- To evaluate the antibacterial activity of APE@ZIF-8 against resistant bacteria.
- To investigate the mechanism of action of the APE@ZIF-8 nanocomposite.
Main Methods:
- Encapsulation of Ajuga parviflora extract (APE) within ZIF-8.
- Characterization of the APE@ZIF-8 nanocomposite.
- Assessment of antibacterial activity against methicillin-resistant Staphylococcus aureus (MRSA) and cephalosporin-carbapenem-resistant Escherichia coli (CCREC).
- Investigation of reactive oxygen species (ROS) generation.
Main Results:
- The APE@ZIF-8 nanocomposite demonstrated significant antibacterial activity against MRSA and CCREC.
- The positively charged APE@ZIF-8 nanoparticles interact electrostatically with negatively charged bacterial surfaces.
- ROS generation was identified as the primary mechanism for bacterial cell damage.
Conclusions:
- The APE@ZIF-8 nanocomposite is a potent antibacterial agent against drug-resistant gram-positive and gram-negative bacteria.
- This nanocomposite has broad application potential for treating infections caused by resistant bacterial strains.
- The findings highlight a novel strategy for combating antimicrobial resistance.
More Related Videos
Related Concept Videos
Combined Effects of Drugs: Synergism
Such synergistic combinations...
Antimicrobial Effectiveness
Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy
Antibiotic Selection
Gene Regulation in Microbial Communities: Quorum Sensing
Development of Antibiotic Resistance

